People

Perlman-276x303
David C. Perlman, MD
CDUHR - Director, Infectious Disease Epidemiology and Social-behavioral Theory Core
Mount Sinai Health System - Professor of Medicine, Icahn School of Medicine
Mount Sinai Health System - Chief, Infectious Diseases, Mount Sinai Beth Israel
Education
MD, Medicine, Albert Einstein College of Medicine
BA. Biochemistry & Anthropology, Dartmouth College
Research Interests
HIV, HCV, IDUs, Diagnosis and treatment
BIO
David Perlman has over 20 years’ experience in HIV, HCV, TB and STIs and remains active as a clinician in these areas. He has served as principal investigator on multi-center trials within NIAID’s AIDS Clinical Trials group, and on R01 grants from NIDA. He has served on NIH study sections, CDC consensus panels, and committees within the ACTG, the NYS DOH AIDS Institute, and the NYC DOMH. Dr. Perlman’s earlier work focused on studies of the epidemiology of tuberculosis among drug users, and on health care delivery models and behavioral and structural interventions to facilitate adherence to the TB and HIV/TB care continuum. Dr. Perlman’s recent work has focused on studies of barriers and facilitators of HIV and HCV testing and care among racial and ethnic minorities, high risk heterosexuals, and people who use drugs, and more broadly on studies of strategies to improve HIV and HIV/HCV care continua and prevention programming for these populations.
Projects
Principal Investigator, Hepatitis Care Coordination in Methadone Treatment. Completed
Publications

Recent

Frank D, Mateu-Gelabert P, Perlman DC, Walters SM, Curran L, Guarino H (2021).
“It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives
Harm Reduction Journal, 18 (1), 88. doi: 10.1186/s12954-021-00535-y. PMCID: PMC8364307.

Metsch LR, Feaster D, Gooden LK, Masson C, Perlman DC, ..., del Rio C (2021).
Care facilitation advances movement along the hepatitis C care continuum for persons with HIV, hepatitis C and substance use: A randomized clinical trial (CTN-0064)
Open Forum Infectious Diseases, 8 (8). doi: 10.1093/ofid/ofab334. PMCID: PMC8339611.

Friedman SR, Mateu-Gelabert P, Nikolopoulos GK, Cerda M, Rossi D, Jordan AE, Townsend T, Khan MR, Perlman DC (2021).
Big events theory and measures may help explain emerging long-term effects of current crises
Global Public Health, 16 (8-9), 1167-1186. doi: 10.1080/17441692.2021.1903528. PMCID: PMC8338763.

Guilamo-Ramos V, Benzekri A, Thimm-Kaiser M, Hidalgo A, Perlman DC (2021).
Reconsidering assumptions of adolescent and young adult SARS-CoV-2 transmission dynamics
Clinical Infectious Diseases, 73 (Suppl 2), S146-S163. doi: 10.1093/cid/ciaa1348. PMCID: PMC7499536.

Ventuneac A, Hecht G, Forcht E, Duah BA, Tarar S, Langenbach B, Gates J, Cain D, Rendina HJ, Aberg JA, Perlman DC (2021).
Chronic high risk prescription opioid use among persons with HIV
Frontiers in Sociology, 6, 104. doi: 10.3389/fsoc.2021.645992. PMCID: PMC8176351.

Dr. Perlman's MyBibliography Profile